Sorainen has advised SafePAS on a EUR 700,000 investment round that saw the participation of Securetec Detektions-Systeme, the Estonian Business Angels Network, PurposeTech, BSV Ventures, and the Beamline Accelerator.
According to Sorainen, the investment round will help SafePAS accelerate the market launch of Drug Hunter, a portable drug detection analyzer developed for onsite use, alongside other next-generation testing tools. Developed in collaboration with the Estonian police and winner of the 2023 Europol Innovation Award, Drug Hunter offers lab-grade precision and cost-effective drug detection capabilities. It can detect 97% of existing drugs in saliva within minutes and is designed for use in the field.
The Sorainen team included Partner Mirell Prosa, Counsel Olivia Kranich, and Associate Eva Lennuk.
Sorainen did not respond to our inquiry on the matter.
